Association Between Antihypertensive Treatment Discontinuation and the Development of Intracerebral Hemorrhage in Japanese Patients With Hypertension: The LIFE Study
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.042523 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Kazuya Honda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences Kyushu University Graduate School of Medical Sciences Fukuoka Japan. Hauptthemen laut MEDLINE: Hypertension, Antihypertensive Agents, Cerebral Hemorrhage, Withholding Treatment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Hypertension is the principal risk factor for intracerebral hemorrhage (ICH), and blood pressure control is reliant on consistent adherence to antihypertensive treatment. This study examined the association between antihypertensive treatment discontinuation and ICH occurrence in Japanese patients with hypertension.
Methods
This nested case–control study was conducted using claims data from the LIFE (Longevity Improvement & Fair Evidence) study from residents of 4 Japanese municipalities enrolled in public medical insurance or public assistance programs. The participants comprised people with hypertension between April and October 2017 and were followed up from November 2017 to March 2022 to identify ICH occurrence. Cases with ICH were matched with controls without ICH in a 1:10 ratio based on sex and age. Participants without any claims data for hypertension care for ≥4 months were regarded as discontinuing antihypertensive treatment. Conditional logistic regression was performed to examine the association between treatment discontinuation and ICH occurrence. Covariates included atrial fibrillation and flutter, diabetes, Charlson Comorbidity Index score, antithrombotic, and statin use.
Results
Of 62 674 patients with hypertension, 5699 (9.1%) developed ICH during follow‐up. Participants who discontinued antihypertensive treatment had significantly higher odds for developing ICH (odds ratio, 3.77 [95% confidence interval, 3.43–4.14]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences Kyushu University Graduate School of Medical Sciences Fukuoka Japan.
- Department of Healthcare Administration and Management Kyushu University Graduate School of Medical Sciences Fukuoka Japan.
ORCID-Profile: Kazuya Honda, Kenichi Goto, Megumi Maeda, Haruhisa Fukuda
Zitieren
APA
Honda, K., Goto, K., Maeda, M., Murata, F., & Fukuda, H. (2025). Association Between Antihypertensive Treatment Discontinuation and the Development of Intracerebral Hemorrhage in Japanese Patients With Hypertension: The LIFE Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042523
Vancouver
Honda K, Goto K, Maeda M, Murata F, Fukuda H. Association Between Antihypertensive Treatment Discontinuation and the Development of Intracerebral Hemorrhage in Japanese Patients With Hypertension: The LIFE Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.042523
BibTeX
@article{Honda2025,
author = {Honda, Kazuya and Goto, Kenichi and Maeda, Megumi and Murata, Fumiko and Fukuda, Haruhisa},
title = {Association Between Antihypertensive Treatment Discontinuation and the Development of Intracerebral Hemorrhage in Japanese Patients With Hypertension: The LIFE Study},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.042523}
}
EUVIMED